Oral lac-phe pill aims to mimic exercise, preserving muscle during weight loss in early trials

TL;DR Summary
Enveda reports Phase 1 results for an oral drug candidate that mimics the exercise-induced lactate-phenylalanine pathway (lac-phe) to curb appetite and preserve lean muscle, with the goal of maintaining weight loss without the GI side effects seen with GLP-1 drugs.
Reading Insights
Total Reads
0
Unique Readers
15
Time Saved
2 min
vs 3 min read
Condensed
91%
449 → 40 words
Want the full story? Read the original article
Read on statnews.com